PTHS PELTHOS THERAPEUTICS INC
FollowCOM SHS (common), issuer CIK 1919246
23 managers (24 13F filers) reported a position in PTHS shares at 2026-06-30, 1,323,163 shares in all. 10 filers opened a position and 3 filers sold out during the quarter.
- Managers
- 23
- 13F filers
- 24
- New
- 10
- Added
- 6
- Reduced
- 3
- Sold out
- 3
- Shares held by filers
- 1,323,163
Shares held by filers adds up every 13F filer's report, so a share reported by a parent and by its subsidiary counts twice (H9). Managers counts each filer group once.
13D and 13G filers
Each filer's latest stake. The shares are the aggregate the reporting persons state, which can include entities that file no 13F.
- LIGAND PHARMACEUTICALS INC
5,189,177 shares, 49.9% in a 13D/A as of 2026-10-30,0001193125-26-445875
Accepted , ingested - 3i, LP
383,447 shares, 9.9% in a 13G/A as of 2026-09-30,0001104659-26-126216
Accepted , ingested
Insider trades
| Owner | Date | Shares | Price | Filing |
|---|---|---|---|---|
| Greenleaf Peterdirector | 2026-10-02 | -797 S | $21.17 | Form 4 |
| Friedberg Ezra Mdirector | 2026-10-02 | -558 S | $20.7169 | Form 4 |
| Pauls Matthewdirector | 2026-10-02 | -786 S | $21 | Form 4 |
13F holders, Q2 2026
Filers in the available 13F reports with a share position at 2026-06-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.
| Holder | Shares | Value | % of portfolio | Change | Source |
|---|---|---|---|---|---|
| AIGH Capital Management LLCin group AIGH Capital Management LLC | 329,098 | $9.3M | 0.84% | new | 13F-HRTimelineGroup |
| Murchinson Ltd.in group Murchinson Ltd. | 304,302 | $8.6M | 4.15% | +7,988 | 13F-HRTimelineGroup |
| Ikarian Capital, LLCin group Ikarian Capital, LLC | 256,598 | $7.25M | 1.19% | 0 | 13F-HRTimelineGroup |
| VANGUARD GROUP INCgroup of 2 filers holding | 107,007 | $3.02M | +4,097 | Timeline
| |
| BOOTHBAY FUND MANAGEMENT, LLC | 101,976 | $2.88M | 0.05% | +20,118 | 13F-HRTimeline |
| CANTOR FITZGERALD, L. P.in group CANTOR FITZGERALD, L. P. | 38,123 | $1.08M | 0.02% | -3,300 | 13F-HR/ATimelineGroup |
| J. Goldman & Co LPin group J. Goldman & Co LP | 38,075 | $1.08M | 0.04% | -12,340 | 13F-HRTimelineGroup |
| DIADEMA PARTNERS LP | 24,773 | $700K | 0.25% | 0 | 13F-HRTimeline |
| WEXFORD CAPITAL LP | 22,364 | $632K | 0.09% | new | 13F-HRTimeline |
| Knott David M Jr | 22,073 | $624K | 0.33% | +1,000 | 13F-HRTimeline |
| CITADEL ADVISORS LLCin group CITADEL ADVISORS LLC | 15,046 | $425K | <0.01% | new | 13F-HR/ATimelineGroup |
| GEODE CAPITAL MANAGEMENT, LLCin group GEODE CAPITAL MANAGEMENT, LLC | 14,650 | $414K | <0.01% | -640 | 13F-HRTimelineGroup |
| Pale Fire Capital SEin group Pale Fire Capital | 12,919 | $365K | 0.03% | 0 | 13F-HRTimelineGroup |
| 1492 Capital Management LLC | 10,380 | $293K | 0.09% | new | 13F-HRTimeline |
| STATE STREET CORPin group STATE STREET CORP | 9,800 | $277K | <0.01% | new | 13F-HR/ATimelineGroup |
| Persistent Asset Partners Ltd | 6,007 | $170K | 0.05% | 0 | 13F-HRTimeline |
| BlackRock, Inc.in group BlackRock, Inc. | 5,324 | $150K | <0.01% | new | 13F-HRTimelineGroup |
| UBS Group AGin group UBS Group AG | 2,217 | $62.7K | <0.01% | +1,453 | 13F-HRTimelineGroup |
| China Universal Asset Management Co., L… | 2,160 | $61K | <0.01% | new | 13F-HRTimeline |
| Tower Research Capital LLC (TRC)in group Tower Research Capital LLC (T… | 205 | $5.79K | <0.01% | new | 13F-HRTimelineGroup |
| Farther Finance Advisors, LLC | 40 | $1.13K | <0.01% | 0 | 13F-HRTimeline |
| BARCLAYS PLCin group BARCLAYS PLC | 20 | $565 | <0.01% | new | 13F-HRTimelineGroup |
| ROYAL BANK OF CANADAin group ROYAL BANK OF CANADA | 6 | $0 | 0% | new | 13F-HR/ATimelineGroupValue filed as zero, left out of ratios. |
Events
3i, LP and 2 other reporting persons reported 383,447 PTHS shares, 9.9% of the class, as of 2026-09-30, in a 13G/A filed 2026-11-12. 0001104659-26-126216
Accepted , ingestedLIGAND PHARMACEUTICALS INC reported 5,189,177 PTHS shares, 49.9% of the class, as of 2026-10-30, in a 13D/A filed 2026-11-03. 0001193125-26-445875
Accepted , ingestedGreenleaf Peter sold 797 PTHS shares on 2026-10-02, Form 4 filed 2026-10-06. 0001919246-26-000131
Accepted , ingestedFriedberg Ezra M sold 558 PTHS shares on 2026-10-02, Form 4 filed 2026-10-06. 0001919246-26-000130
Accepted , ingestedPauls Matthew sold 786 PTHS shares on 2026-10-02, Form 4 filed 2026-10-06. 0001919246-26-000129
Accepted , ingested